Cargando…
Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals
Atherosclerosis, a systemic disease, is the predominant cause of cardiovascular disease (CVD) that far exceeds other causes (egs: congenital, hypertension, arrhythmia). CVD is the leading cause of mortality globally (18 million lives, including 9 million from coronary artery disease (CAD) annually)....
Autores principales: | Enas, Enas A., Varkey, Basil, Gupta, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296246/ https://www.ncbi.nlm.nih.gov/pubmed/32534692 http://dx.doi.org/10.1016/j.ihj.2020.03.015 |
Ejemplares similares
-
Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians
por: Enas, Enas A., et al.
Publicado: (2019) -
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians – A population with the highest risk of premature coronary artery disease & diabetes
por: Enas, Enas A., et al.
Publicado: (2013) -
Highlights in ASCVD Primary Prevention for 2021
por: Polonsky, Tamar S., et al.
Publicado: (2022) -
Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia
por: Zhang, Lei, et al.
Publicado: (2019) -
Health Literacy is Essential to ASCVD Prevention in Youth
por: Mann, Harnoor K., et al.
Publicado: (2023)